my patient can’t sleep – how can we avoid over-use of

42
West Midlands Centre for ADRs 1 My patient can’t sleep – how can we avoid over-use of sleeping pills? Robin Ferner University of Birmingham

Upload: others

Post on 18-Dec-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

West M

idla

nds C

entre

for A

DR

s

1

My patient can’t sleep – how can

we avoid over-use of sleeping pills?

Robin Ferner

University of Birmingham

West M

idla

nds C

entre

for A

DR

s

Declarations

2

I have provided medico-legal opinions on

harm from drugs

I generally sleep soundly

West M

idla

nds C

entre

for A

DR

s

Do you sleep soundly:

3

POLL

OPEN

1 Always18.18%

2 Usually45.45%

3 Sometimes27.27%

4 Rarely9.09%

5 Never0%

West M

idla

nds C

entre

for A

DR

s

Sleep

Definition – tricky

Physical quiescence + arousal threshold + rapid reversibility

Functions of sleep – speculative, e.g.

Neuronal housekeeping: brain repair, network reorganization

Cleansing: removing free radicals, neurotoxins

Energy allocation: physiological function -v- energy conservation

&c

4

Assefa. AIMS Neuroscience 2015; 2: 155-171

West M

idla

nds C

entre

for A

DR

s

Neurobiology of wakefulness & sleep

5

Orexin

Ascending reticular

activating system

Melatonin

(REM) sleep

GABA

Adrenaline

Serotonin

SleepWakefulness

West M

idla

nds C

entre

for A

DR

s

Stages of sleep

6

Stage 1 Stage 2 Stage 3

2

Rapid Eye

Movement

2 2 22

Most drugs disturb “sleep architecture”

“sleep architecture”

West M

idla

nds C

entre

for A

DR

s

Insomnia

7 Tobaldini. Nature Reviews Cardiology 2019; 16: 213-224

Clinical feature Experimental measure

Difficulty in going to sleep sleep onset latency

Difficulty staying asleep waking after sleep onset

total sleep time

Unrefreshing sleep Pittsburgh Sleep Quality Index

Maximum (worst) 21/21

Incidence – up to 1/3 of all adults, increases with age

Effects – bad for psyche, performance, physiology

depression, errors, cardiometabolic risk

West M

idla

nds C

entre

for A

DR

s

Treatment: NICE Knowledge Summary

8

1. Remove underlying causes if possible

4. Advise good sleep hygiene

2. Give advice on driving

3. Refer for Cognitive Behavioural Therapy

5. If Severe symptoms or

Acute exacerbation… short-term ℞

West M

idla

nds C

entre

for A

DR

s

Potentially alleviable impediments to normal sleep (PAINS)

Pain, pruritus, prostatism…

Anxiety

Insomnia syndromes

Nuisances, neighbours, noisiness

Stimulants

9

1. Remove underlying causes if possible

West M

idla

nds C

entre

for A

DR

s

Insomnia syndromes

10

Sleep-related

breathing disorders

Central

hypersomnolence

Circadian rhythm

disorders

Sleep-related

movement disorders

Parasomnias

‘Insomnia disorder’

Narcolepsy

(orexin deficiency)

JW Waterhouse 1872 Undine

1RY central sleep

apnoea

Jet lag

Sleep-related

bruxism

Sleepwalking

Sateia. International Class-

ification of Sleep Disorders-

Third Edition. Chest 2014;

146: 1387-94

West M

idla

nds C

entre

for A

DR

s

Cochrane review of 6 trials, total 224 patients over 60

11

“The data suggest a mild effect of CBT for different aspects of the

sleep problems in older adults.”

ψ 3. Refer for Cognitive Behavioural Therapy

Change, CBT -v- control

Sleep onset latency NS

Wake after sleep onset

Sleep duration

-21% (NS at 12/12)

NS

Montgomery. Cochrane Database Systematic Rev 2003:

CD003161.

West M

idla

nds C

entre

for A

DR

s

12

50 students – poor sleepers in three groups

“choose an image; focus on it for 120 s”

“think over the day”

“no instruction”

Concrete imagery and sleep

Sleep latency (min)

Harvey. Behaviour Res Therap 2002; 40: 267–277

“brief training in the identification and elaboration of an

engaging and interesting imagery task … reduced

discomfort associated with unwanted pre-sleep

cognitive activity and reduced sleep onset latency.”

ψ

West M

idla

nds C

entre

for A

DR

s

https://www.nhs.uk/live-well/sleep-and-tiredness/10-tips-to-beat-insomnia/

4. Advise good sleep hygiene

West M

idla

nds C

entre

for A

DR

s

A review of empirical evidence

…though epidemiologic and experimental research

generally supported an association between individual

sleep hygiene recommendations and nocturnal sleep, the

direct effects of individual recommendations on sleep

remains largely untested in the general population.

14

Irish. Sleep Medicine Reviews 2015;22: 23-36

West M

idla

nds C

entre

for A

DR

s

Exercise and sleep

16 weeks of exercise in 43 older people

Walking 30–40 min x 4/week

15

Active Control

Sleep latency 15 min 24 min

Sleep duration 6.8 h 6.0 h

Pittsburgh Index* 5.4 8.8

King. JAMA1997;277:32-7

*Pittsburgh Sleep Quality Index:

questionnaire, maximum (worst) score is 21/21

West M

idla

nds C

entre

for A

DR

s

Exercise and sleep

Chronic exercise

Total sleep time (?)

Sleep onset latency (?)

Episodes of wakefulness (?)

A catch:

May not make (middle-aged ♀) patients feel better

16

Driver. Sleep Med Rev 2000; 4: 387-402

Rubio-Arias. Maturitas 2017; 100: 49-56

West M

idla

nds C

entre

for A

DR

s

T’ai chi and sleep

Change,

T’ai Chi

Change,

Control

Sleep latency -23 min -5.6 min

Sleep duration +0.87 h +0.06 h

Pittsburgh Index -0.92 -0.18

17

6 months T’ai chi -v- 6 months low intensity exercise

62 -v- 56; mean age 75 y

Li. J Am Geriatr Soc 52:892–900, 2004

West M

idla

nds C

entre

for A

DR

s

Favours music Favours control

Music and sleep

Five trials of listening to pre-recorded music once a day for ¾ h

Heterogeneous music types

Active 134 patients, control 130 patients: mean difference -2.8

18

Jespersen. Cochrane 2015; CD010459

Mean Δ in Pittsburgh Index

Random, 95% CI

West M

idla

nds C

entre

for A

DR

s

Malted milk drink at bed-time and sleep

Horlicks®

Placebo

Hour of sleep1st 6th

Mean

minutes of

intervening

wakefulness

2

4

6

8

Bŕezinóva BMJ 1972; 2: 431-433

We are indebted to Beecham Inc., Clifton, New

Jersey, U.S.A, for supplies of Horlicks powder

8 subjects

West M

idla

nds C

entre

for A

DR

s

Spicy meals and sleep

20

Spicy meal Control

Sleep latency 34.8 min 16.1 min

Sleep duration 423 min 445 min

Time awake 43 min 25 min

Edwards. Int J Psychophysiol 1992;13: 97-100

Six young men

Cross-over study

With or without Tabasco® + mustard

West M

idla

nds C

entre

for A

DR

s

21

Non-pharmacological measures have failed

Use cheapest Z-drug/short-acting benzo

Insomnia is interfering with normal daily life

Treatment is for a short period only

Switch only if there is an ADR

5. Short-term ℞

West M

idla

nds C

entre

for A

DR

s

Drugs inducing sleep

• γ-amino-butyric acid

• Barbiturates

• Benzodiazepines

• Ethanol

• Meprobamate

• Neurosteroids

• Propofol

• Z-drugs

22

Cl-

Melatonin

receptor

agonists

GABAA agonists

Orexin

receptor

antagonists

Anti-

depressants

West M

idla

nds C

entre

for A

DR

s

Barbiturates – 1904

At least 50 marketed

They work

Veronal® (barbitone) – British Pharmacopoeia 1914

23

Jordan AC. BMJ 1904 (2253):538-9

West M

idla

nds C

entre

for A

DR

s

Barbiturate deaths, England and Wales

24

López-Muñoz. Neuropsych Dis Treat 2005; 1:329–343

West M

idla

nds C

entre

for A

DR

s

Benzodiazepines - 1960

Augment the effects of GABA at the receptor

Safe in overdose

Anxiolytic

25

extends into the field of the sedativescovers the field of meprobamateextends into the field of the phenothiazinesexerts an effect in some cases that respond to reserpine

West M

idla

nds C

entre

for A

DR

s

Benzodiazepines – 20 years on

‘Evidence is rapidly accumulating that benzodiazepines are

potentially drugs of dependence, that chronic use is

associated with adverse effects, and that withdrawal may

produce a definite abstinence syndrome.'

26

Ashton H. BMJ 1984; 288: 1135-1140

‘Because of the risk of dependence on benzodiazepines

these agents should probably not be given as regular daily

treatment for chronic anxiety.’ Petursson H. BMJ 1981; 283: 643-645

West M

idla

nds C

entre

for A

DR

s

Benzodiazepines now

Temazepam indicated for:

The short-term treatment of insomnia only when

it is severe, disabling, or subjecting the individual

to extreme stress, especially for those patients in

whom the persistence of a hypnotic effect would

be undesirable.

27

SPC Temazepam

West M

idla

nds C

entre

for A

DR

s

‘The dark side of benzodiazepines’

Hangover effects

Cognitive impairment

Memory impairment

Falls

Road traffic collisions (RR ~ 2)

Rebound insomnia, dependence, abuse

28

AtkinT. Pharmacol Rev 2018; 70: 197-245

West M

idla

nds C

entre

for A

DR

s

Temazepam prescribing in England

2014 - 2019

29

0

30,000

60,000

90,000

120,000

150,000

10/06/2014 15/07/2015 18/08/2016 22/09/2017 27/10/2018 01/12/2019

https://openprescribing.net/

Items

Benzodiazepine prescriptions for at least 3 years:

120,000 patients in England Public Health England September 2019

West M

idla

nds C

entre

for A

DR

s

The Z-drugs

Bind mainly at GABAA α1 subunit

(benzos bind at α1, 2, 3, 5)

Sedative and hypnotic, but less anxiolytic

ADRs very similar to benzodiazepines

30

West M

idla

nds C

entre

for A

DR

s

Risk of hip fracture with hypnotics

Benzodiazepines or Z-drugs

Use up to 14 days: RR 2.4 [1.9–3.1]

Z-drugs

Use up to 14 days : RR 2.4 [1.7–3.3]

31

Donnelly. 2017. PlosOne 12(4): e0174730

West M

idla

nds C

entre

for A

DR

s

Zolpidem and sleep

6 patients with insomnia

Treated for 18 nights, then withdrawn over 3 nights

32

Baseline Zolpidem Withdrawal

Sleep latency 65.7 min 24.3 min 53.8 min

Sleep duration 333 min 385 min 354 min

Monti. Eur J Clin Pharm 1989; 36: 461-466

West M

idla

nds C

entre

for A

DR

s

Melatonin and sleep

33 Wade BMC Medicine 2010, 8:51

930

373

373

534

177

Active

Pla

cebo

SR

melatonin

Control

Δ Sleep latency -26 min -8.3 min P <0.001

Δ Sleep duration +0.64 h +0.41 h NS

Pittsburgh index -0.39 -0.17 NS

Adults aged 65–80 years 159 active -v- 61 placebo

West M

idla

nds C

entre

for A

DR

s

Melatonin and sleep

Four trials (845 patients), evidence ‘weak, in favour’

34

Costello. Nutrition J 2014; 13: 106

West M

idla

nds C

entre

for A

DR

s

Antidepressants and sleep

35

“There may be a small improvement in sleep quality with

short‐term use of low‐dose doxepin and trazodone

compared with placebo.”

Everitt. Cochrane 2018;CD010753

West M

idla

nds C

entre

for A

DR

s

Suvorexant* and sleepAn orexin antagonist

Suvorexant

(290)

Control

(193)

Δ Sleep latency -35 min - 27 min

Δ Sleep duration + 51 min + 41 min

36

Belsomra® Label

*Unlicensed medicine

West M

idla

nds C

entre

for A

DR

s

So

There are few satisfactory trials

Usually short

Often small

Uncommonly in insomniacs

Measures are either subjective or complex

Objective and subjective measures conflict

The trials don’t measure dependence

37

West M

idla

nds C

entre

for A

DR

s

Conclusions

At least sleep hygiene, exercise, and music

aren’t “odious”

38

Carswell BMJ 1927;i: 1163

“Every hypnotic has been "scientifically”

condemned, and the condemnation has

always been accompanied by a certain

suggestion that the prescriber as well as the

patient is, or is likely to become, an odious

person.”

West M

idla

nds C

entre

for A

DR

s

39

West M

idla

nds C

entre

for A

DR

s

Alcohol and sleep

Standard view:

Alcohol sleep latency, then waking later in the night

(?acute alcohol withdrawal)

But

Dose required to sleep latency is lower

67% insomniac patients slept ‘better’ with alcohol

40

Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and

alcohol use and abuse. Sleep Med Rev 2001;5:287e97.

Pressman. Alcohol and Sleep Review: Flawed Design, Methods, and

Statistics Cannot Support Conclusions. Alc Clin Exp 2015; 39: 941-3

Ebrahim. Alcohol and Sleep I: Effects on Normal Sleep. Alc Clin Exp 2013

West M

idla

nds C

entre

for A

DR

s

Z-drug prescribing in England

41

0

200,000

400,000

600,000

10/06/2014 15/07/2015 18/08/2016 22/09/2017 27/10/2018 01/12/2019

Items

West M

idla

nds C

entre

for A

DR

s

Blue light and sleep

Bright blue-enriched polychromatic light is no more

effective than standard bright light therapy for phase

advancing circadian rhythms at commonly used

therapeutic light levels

42

Smith. Sleep Med. 2009 March ; 10(3): 287–294